TGFB1 and pancreatic neoplasm: Moreover, metabolic reprogramming during EMT has been shown to involve the suppression of glycolytic flux and upregulation of oxidative metabolism also in colorectal and pancreatic cancer cell lines [95,96], consistent with our observation of reduced glycolytic activity in Huh7 cells following TGF-β1 exposure.